Increasing GLP-1 dose if not at max
Comprehensive Approach: Addresses both structural repair (collagen, extracellular matrix) and cellular aspects (migration, proliferation) of healing
As it doesnt have FDA approval, it may have limited availability
Diabetes medications may need clinician review if glucose changes with reduced intake
Not everyone is a good candidate for peptide-based weight-loss treatments
A more comprehensive MCAS treatment approach may be worth exploring if: you have multisystem symptoms that seem inflammatory or allergy-like antihistamines only partly help triggers feel broad, inconsistent, or hard to predict food reactivity has become increasingly limiting digestive symptoms are a major part of the problem stress clearly worsens flares you suspect histamine burden, MCAS, or mast cell instability but want a more complete evaluation This kind of approach may also be relevant for patients who feel caught between diagnoses, such as those told they have IBS, sensitivities, chronic inflammation, or unexplained immune symptoms without a clear unifying framework